For investors only

All about the drug candidate arfolitixorin
and related information

ESMO 2019, poster

Isofol will attend at the 2019 European Society of Medical Oncology (ESMO) Congress, which is being held from September 27 to October 1, 2019, in Barcelona, Spain.

Details on the presentation are as follows:

Title: Open label phase III study of arfolitixorin vs leucovorin in mFOLFOX-6 for first-line treatment of metastatic colorectal cancer: AGENT

Presentation Number: 664TiP

Presentation Time: 12 p.m. – 1 p.m. CEST

Presentation Date: September 29, 2019

Speaker: Prof Sebastian Stintzing

Session Name: Poster Display session

Location: Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain

The poster will be exposed on September 29 at 09:00 in Hall 4. At that same time you are able to download it here:

Poster, ESMO meeting 2019 (2 Mb)

Link to the abstract >>



Last updated 05-22-2024

Scroll to Top